Evidence map›Paper›PMID 26821841›Full record

ArticlePharmaceutical development and technology2017

Investigation of the combined effect of MgO and PEG on the release profile of mefenamic acid prepared via hot-melt extrusion techniques.

Sultan M Alshehri, Roshan V Tiwari, Bader B Alsulays, Eman A Ashour, Abdullah S Alshetaili, Bjad Almutairy, Jun-Bom Park, Joseph Morott, Bhupinder Sandhu, Soumyajit Majumdar and 1 more

Open access · greenAbstract read
In one paragraph

Article in Pharmaceutical development and technology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Dissolution and bioavailability improvement of bioactive apigenin using solid dispersions prepared by different techniques.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2019
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Sultan M Alshehria Department of Pharmaceutics and Drug Delivery , School of Pharmacy, The University of Mississippi, University , MS , USA.
Roshan V Tiwaria Department of Pharmaceutics and Drug Delivery , School of Pharmacy, The University of Mississippi, University , MS , USA.
Bader B Alsulaysb Department of Pharmaceutics , College of Pharmacy, Prince Sattam Bin Abdulaziz University , Alkharj , Saudi Arabia.
Eman A Ashoura Department of Pharmaceutics and Drug Delivery , School of Pharmacy, The University of Mississippi, University , MS , USA.
Abdullah S Alshetailib Department of Pharmaceutics , College of Pharmacy, Prince Sattam Bin Abdulaziz University , Alkharj , Saudi Arabia.
Bjad Almutairya Department of Pharmaceutics and Drug Delivery , School of Pharmacy, The University of Mississippi, University , MS , USA.
Jun-Bom Parkc College of Pharmacy, Sahm Yook University , Seoul , Korea.
Joseph Morotta Department of Pharmaceutics and Drug Delivery , School of Pharmacy, The University of Mississippi, University , MS , USA.
Bhupinder Sandhud Department of Chemistry , Kansas State University , Manhattan , KS , USA , and.
Soumyajit Majumdara Department of Pharmaceutics and Drug Delivery , School of Pharmacy, The University of Mississippi, University , MS , USA.
Michael A Repkaa Department of Pharmaceutics and Drug Delivery , School of Pharmacy, The University of Mississippi, University , MS , USA.
University of Mississippi · USPrince Sattam Bin Abdulaziz University · SAKansas State University · USSahmyook University · KR

Funding

Center of Research Excellence in Natural Products Neuroscience (CORE-NPN)P20GM104932 · NIGMS · UNIVERSITY OF MISSISSIPPI · PI MAJUMDAR, SOUMYAJIT · 2012 to 2016
$10.0M
NIGMS NIH HHS P20 GM104932
6 · The paper itself

Abstract

This study aimed to investigate the combined effect of magnesium oxide (MgO) as an alkalizer and polyethylene glycol (PEG) as a plasticizer and wetting agent in the presence of Kollidon® 12 PF and 17 PF polymer carriers on the release profile of mefenamic acid (MA), which was prepared via hot-melt extrusion technique. Various drug loads of MA and various ratios of the polymers, PEG 3350 and MgO were blended using a V-shell blender and extruded using a twin-screw extruder (16-mm Prism EuroLab, ThermoFisher Scientific, Carlsbad, CA) at different screw speeds and temperatures to prepare a solid dispersion system. Differential scanning calorimetry and X-ray diffraction data of the extruded material confirmed that the drug existed in the amorphous form, as evidenced by the absence of corresponding peaks. MgO and PEG altered the micro-environmental pH to be more alkaline (pH 9) and increased the hydrophilicity and dispersibility of the extrudates to enhance MA solubility and release, respectively. The in vitro release study demonstrated an immediate release for 2 h with more than 80% drug release within 45 min in matrices containing MgO and PEG in combination with polyvinylpyrrolidone when compared to the binary mixture, physical mixture and pure drug.

Indexed as

Drug CompoundingMagnesium OxideMefenamic AcidPolyethylene GlycolsCalorimetry, Differential ScanningChemistry, PharmaceuticalDrug CarriersHot TemperatureSolubilityDrug CarriersMagnesium OxideMefenamic AcidPolyethylene GlycolsHot-melt extrusionKollidon® 12 PF and 17 PFmagnesium oxidemefenamic acidpolyethylene glycol

Identifiers

PMID26821841
PMCPMC5578468
OpenAlexW2291453520

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.